Skip to content

Author

A. Brucato

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Early Introduction and Prolonged Full-Dose Anakinra Reduce Recurrence Risk After Discontinuation in Recurrent Pericarditis: An International Multicenter Cohort.

BACKGROUND Anakinra is effective in recurrent pericarditis, yet optimal treatment duration and strategies for safe drug discontinuation remain uncertain. Identifying predictors of sustained remission after discontinuation is important for clinical management. METHODS We retrospectively analyzed 185 consecutive adult...

Danilo Malandrino, Alessandra Bettiol, A. Andreis et al. · 0 citations
Open access Sep 2026

Real-world effectiveness and safety of secukinumab in giant cell arteritis: an Italian multicentre cohort study.

In this multicentre real-world cohort of patients with GCA, including those with relapsing disease and previous biologic exposure, secukinumab was associated with high observed remission rates, progressive GC dose reduction and increasing GC-free remission.

Luca Iorio, Federica Davanzo, C. Ricordi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.